539730 — Fredun Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Fredun Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	C2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11.9	21.3	162	55.5	71.3
Net Total Accounts Receivable
Net Total Receivables	610	1,035	491	752	1,778
Total Inventory
Total Other Current Assets
Total Current Assets	1,301	1,526	2,162	2,572	4,280
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	304	323	386	462	525
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,616	1,870	2,573	3,076	4,874
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	865	738	1,397	1,668	3,281
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,185	1,189	1,609	1,861	3,460
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	431	681	964	1,215	1,414
Total Liabilities & Shareholders' Equity	1,616	1,870	2,573	3,076	4,874
Total Common Shares Outstanding